MicroRNA-371-3 cluster as biomarkers for the diagnosis and prognosis of cancers

References

• Lee RC, Feinbaum RL, Ambros V. The C. elegans heterochronic gene lin-4 encodes small rnas with antisense complementarity to lin-14. Cell. 1993;75:843–854.8252621
   PubMed Web of Science ®Google Scholar
• Carthew RW, Sontheimer EJ. Origins and mechanisms of mirnas and sirnas. Cell. 2009;136:642–655. doi:10.1016/j.cell.2009.01.03519239886
   PubMed Web of Science ®Google Scholar
• Bracken CP, Scott HS, Goodall GJ. A network-biology perspective of microrna function and dysfunction in cancer. Nat Rev Genet. 2016;17:719–732. doi:10.1038/nrg.2016.13427795564
   PubMed Web of Science ®Google Scholar
• Bragato JP, Melo LM, Venturin GL, Rebech GT, Garcia LE, Lopes FL. Relationship of peripheral blood mononuclear cells mirna expression and parasitic load in canine visceral leishmaniasis. PloS One 2018;13:e0206876.30517108
   PubMed Web of Science ®Google Scholar
• Edwardson MA. Plasma microrna markers of upper limb recovery following human stroke. PLoS One. 2018;8:12558.
   Google Scholar
• Zhang W, Wang Y. Serum mir-200c and mir-371-5p as the useful diagnostic biomarkers and therapeutic targets in Kawasaki disease. BioMed Res Int. 2017;2017:8257862.28656149
   PubMed Web of Science ®Google Scholar
• Ullmann P, Rodriguez F, Schmitz M, et al. The mir-371 approximately 373 cluster represses colon cancer initiation and metastatic colonization by inhibiting the tgfbr2/id1 signaling axis. Cancer Res 2018;78:3793–3808. doi:10.1158/0008-5472.CAN-17-300329748374
   PubMed Web of Science ®Google Scholar
• Sahu N, Stephan JP, Cruz DD, et al. Functional screening implicates mir-371-3p and peroxiredoxin 6 in reversible tolerance to cancer drugs. Nat Commun. 2016;7:12351. doi:10.1038/ncomms1235127484502
   PubMed Web of Science ®Google Scholar
• Haan S, Letellier E, Guo H, et al. Microrna-371a-3p promotes progression of gastric cancer by targeting tob1. Cancer Res. 2019;443:179–188.
   Google Scholar
• Classon M, Settleman J, Ullmann P, et al. The mir-371 approximately 373 cluster represses colon cancer initiation and metastatic colonization by inhibiting the tgfbr2/id1 signaling axis. Nat Commun. 2018;78:3793–3808.
   Google Scholar
• Murray MJ, Huddart RA, Coleman N. The present and future of serum diagnostic tests for testicular germ cell tumours. Nat Rev Urol. 2016;13:715–725. doi:10.1038/nrurol.2016.17027754472
   PubMed Web of Science ®Google Scholar
• Voorhoeve PM, le Sage C, Schrier M, et al. A genetic screen implicates mirna-372 and mirna-373 as oncogenes in testicular germ cell tumors. Cell. 2006;124:1169–1181. doi:10.1016/j.cell.2006.02.03716564011
   PubMed Web of Science ®Google Scholar
• Huang X, Huang M, Kong L, Li Y. Mir-372 suppresses tumour proliferation and invasion by targeting igf2bp1 in renal cell carcinoma. Cell Prolif. 2015;48:593–599. doi:10.1111/cpr.1220726332146
   PubMed Web of Science ®Google Scholar
• Huang Q, Gumireddy K, Schrier M, et al. The micrornas mir-373 and mir-520c promote tumour invasion and metastasis. Nat Cell Biol. 2008;10:202–210. doi:10.1038/ncb168118193036
   PubMed Web of Science ®Google Scholar
• Wang L, Qu J, Zhou L, Liao F, Wang J. Microrna-373 inhibits cell proliferation and invasion via targeting brf2 in human non-small cell lung cancer a549 cell line. Cancer Res Treat. 2018;50(3):936–949.
   Web of Science ®Google Scholar
• Dieckmann KP, Radtke A, Spiekermann M, et al. Serum levels of microrna mir-371a-3p: A sensitive and specific new biomarker for germ cell tumours. Eur Urol. 2017;71:213–220. doi:10.1016/j.eururo.2016.07.02927495845
   PubMed Web of Science ®Google Scholar
• Syring I, Bartels J, Holdenrieder S, Kristiansen G, Muller SC, Ellinger J. Circulating serum mirna (mir-367-3p, mir-371a-3p, mir-372-3p and mir-373-3p) as biomarkers in patients with testicular germ cell cancer. J Urol. 2015;193:331–337. doi:10.1016/j.juro.2014.07.01025046619
   PubMed Web of Science ®Google Scholar
• Liu H, Zhu L, Liu B, et al. Genome-wide microrna profiles identify mir-378 as a serum biomarker for early detection of gastric cancer. Cancer Lett. 2012;316:196–203. doi:10.1016/j.canlet.2011.10.03422169097
   PubMed Web of Science ®Google Scholar
• Hua Y, Chen H, Wang L, et al. Low serum mir-373 predicts poor prognosis in patients with pancreatic cancer. Cancer Biomarkers. 2017;20:95–100. doi:10.3233/CBM-17023128759959
   PubMed Web of Science ®Google Scholar
• Eichelser C, Flesch-Janys D, Chang-Claude J, Pantel K, Schwarzenbach H. Deregulated serum concentrations of circulating cell-free micrornas mir-17, mir-34a, mir-155, and mir-373 in human breast cancer development and progression. Clin Chem. 2013;59:1489–1496. doi:10.1373/clinchem.2013.20516123748853
   PubMed Web of Science ®Google Scholar
• Chen W, Cai F, Zhang B, Barekati Z, Zhong XY. The level of circulating mirna-10b and mirna-373 in detecting lymph node metastasis of breast cancer: potential biomarkers. Tumour Biol. 2013;34:455–462. doi:10.1007/s13277-012-0570-523238818
   PubMedGoogle Scholar
• Wu G, Wang Y, Lu X, et al. Low mir-372 expression correlates with poor prognosis and tumor metastasis in hepatocellular carcinoma. BMC Cancer. 2015;15:182. doi:10.1186/s12885-015-1584-325880458
   PubMed Web of Science ®Google Scholar
• Zhang Q, Wang C, Miao S, Li C, Chen Z, Li F. Enhancing e-cadherin expression via promoter-targeted mir-373 suppresses bladder cancer cells growth and metastasis. Oncotarget. 2017;8:93969–93983. doi:10.18632/oncotarget.2140029212202
   PubMedGoogle Scholar
• Jing SY, Jing SQ, Liu LL, Xu LF, Zhang F, Gao JL. Down-expression of mir-373 predicts poor prognosis of glioma and could be a potential therapeutic target. Eur Rev Med Pharmacol Sci. 2017;21:2421–2425.28617546
   PubMed Web of Science ®Google Scholar
• Bellmunt J, Zhou CW, Mullane SA, et al. Association of tumour microrna profiling with outcomes in patients with advanced urothelial carcinoma receiving first-line platinum-based chemotherapy. Br J Cancer. 2016;115:12–19. doi:10.1038/bjc.2016.14627351382
   PubMed Web of Science ®Google Scholar
• Tu HF, Chang KW, Cheng HW, Liu CJ. Upregulation of mir-372 and −373 associates with lymph node metastasis and poor prognosis of oral carcinomas. Laryngoscope. 2015;125:E365–370. doi:10.1002/lary.2546426152520
   PubMed Web of Science ®Google Scholar
• Li G, Zhang Z, Tu Y, et al. Correlation of microrna-372 upregulation with poor prognosis in human glioma. Diagn Pathol. 2013;8:1. doi:10.1186/1746-1596-8-123298385
   PubMed Web of Science ®Google Scholar
• Yamashita S, Yamamoto H, Mimori K, et al. Microrna-372 is associated with poor prognosis in colorectal cancer. Oncology. 2012;82:205–212. doi:10.1159/00033680922456107
   PubMed Web of Science ®Google Scholar
• Gu H, Guo X, Zou L, Zhu H, Zhang J. Upregulation of microrna-372 associates with tumor progression and prognosis in hepatocellular carcinoma. Mol Cell Biochem. 2013;375:23–30. doi:10.1007/s11010-012-1521-623291979
   PubMed Web of Science ®Google Scholar
• Meng X, Pantel MV, Schwarzenbach H. Diagnostic and prognostic relevance of circulating exosomal mir-373, mir-200a, mir-200b and mir-200c in patients with epithelial ovarian cancer. Oncotarget. 2016. doi:10.18632/oncotarget.7850
   Google Scholar
• Tierney JF, Stewart LA, Ghersi D, Burdett S, Sydes MR. Practical methods for incorporating summary time-to-event data into meta-analysis. Trials. 2007;8:16. doi:10.1186/1745-6215-8-1617555582
   PubMed Web of Science ®Google Scholar
• Mahid SS, Hornung CA, Minor KS, Turina M, Galandiuk S. Systematic reviews and meta-analysis for the surgeon scientist. Br J Surg. 2006;93:1315–1324. doi:10.1002/bjs.559617058324
   PubMed Web of Science ®Google Scholar
• Stang A. Critical evaluation of the newcastle-ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol. 2010;25:603–605. doi:10.1007/s10654-010-9491-z20652370
   PubMed Web of Science ®Google Scholar
• Razzak R, Bedard EL, Kim JO, et al. Microrna expression profiling of sputum for the detection of early and locally advanced non-small-cell lung cancer: A prospective case-control study. Current Oncol. 2016;23:e86–94. doi:10.3747/co.23.2830
   PubMed Web of Science ®Google Scholar
• Kim JO, Gazala S, Razzak R, et al. Non-small cell lung cancer detection using microrna expression profiling of bronchoalveolar lavage fluid and sputum. Anticancer Res. 2015;35:1873–1880.25862841
   PubMed Web of Science ®Google Scholar
• Lee KH, Goan YG, Hsiao M, et al. Microrna-373 (mir-373) post-transcriptionally regulates large tumor suppressor, homolog 2 (lats2) and stimulates proliferation in human esophageal cancer. Exp Cell Res. 2009;315:2529–2538. doi:10.1016/j.yexcr.2009.06.00119501585
   PubMed Web of Science ®Google Scholar
• Guo H, Liu H, Mitchelson K, et al. Micrornas-372/373 promote the expression of hepatitis b virus through the targeting of nuclear factor i/b. Hepatology. 2011;54:808–819. doi:10.1002/hep.2444121608007
   PubMed Web of Science ®Google Scholar
• Eichelser C, Stuckrath I, Muller V, et al. Increased serum levels of circulating exosomal microrna-373 in receptor-negative breast cancer patients. Oncotarget. 2014;5:9650–9663. doi:10.18632/oncotarget.252025333260
   PubMed Web of Science ®Google Scholar
• Wang LQ, Yu P, Li B, et al. Mir-372 and mir-373 enhance the stemness of colorectal cancer cells by repressing differentiation signaling pathways. Mol Oncol. 2018;12:1949–1964. doi:10.1002/1878-0261.1237630171794
   PubMed Web of Science ®Google Scholar
• Zhang Y, Yang J, Cui X, et al. A novel epigenetic creb-mir-373 axis mediates zip4-induced pancreatic cancer growth. EMBO Mol Med. 2013;5:1322–1334. doi:10.1002/emmm.20130250723857777
   PubMed Web of Science ®Google Scholar
• Wei F, Cao C, Xu X, Wang J. Diverse functions of mir-373 in cancer. J Transl Med. 2015;13:162. doi:10.1186/s12967-015-0541-x25990556
   PubMed Web of Science ®Google Scholar
• Adi Harel S, Bossel Ben-Moshe N, Aylon Y, et al. Reactivation of epigenetically silenced mir-512 and mir-373 sensitizes lung cancer cells to cisplatin and restricts tumor growth. Cell Death Differ. 2015;22:1328–1340. doi:10.1038/cdd.2014.22125591738
   PubMed Web of Science ®Google Scholar
• Crosby ME, Kulshreshtha R, Ivan M, Glazer PM. Microrna regulation of DNA repair gene expression in hypoxic stress. Cancer Res. 2009;69:1221–1229. doi:10.1158/0008-5472.CAN-08-251619141645
   PubMed Web of Science ®Google Scholar